4.6 Article

A practical guide to the use of repetitive transcranial magnetic stimulation in the treatment of depression

期刊

BRAIN STIMULATION
卷 5, 期 3, 页码 287-296

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.brs.2011.03.006

关键词

repetitive transcranial magnetic stimulation; depression; prefrontal; administration; maintenance

资金

  1. NHMRC
  2. Canadian Institutes of Health Research (CIHR)
  3. National Alliance for Research on Schizophrenia and Depression (NARSAD)
  4. Neuronetics Inc
  5. Aspect Medical Inc

向作者/读者索取更多资源

Background Repetitive transcranial magnetic stimulation (rTMS) is currently emerging as a new treatment for patients with mood disorders. Research into the use of rTMS for the treatment of patients with depression has been conducted now for a period of greater than 15 years and a considerable body of knowledge has accumulated informing its use. Objective The aim of this paper was to review the use of various rTMS techniques for the treatment of depression and to provide practical suggestions to address the common issues encountered in the prescribing and administration of rTMS treatment. Methods These suggestions have been informed both by a review of the relevant literature and the experience of the authors in the treatment of many patients with depression with rTMS over a period of 10 years. Results and Conclusions High-frequency rTMS applied to the left dorsolateral prefrontal cortex, using a set of parameters very similar to those originally described in the mid-1990s, is an effective treatment for patients with major depressive disorder. Other forms of stimulation, such as low-frequency stimulation applied to the right prefrontal cortex and bilateral approaches, may prove valuable but require evaluation in larger trials. Significant benefit appears likely to accumulate through the use of methods that involve a more reliable targeting of prefrontal brain regions. Suggestions are also made around the use of rTMS treatment as a maintenance therapy and in specific illness subgroups. (C) 2012 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Neurosciences

Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression

F. H. Robin Cash, Anne Weigand, Andrew Zalesky, H. Shan Siddiqi, Jonathan Downar, B. Paul Fitzgerald, D. Michael Fox

Summary: Research indicates that using neuroimaging to identify a more precise therapeutic target for depression is crucial for the effectiveness of TMS treatment. New methods allow for precise positioning of the TMS coil, and targeting the frontal cortex with functional connectivity to deep limbic regions may be a more effective approach.

BIOLOGICAL PSYCHIATRY (2021)

Article Clinical Neurology

Characterizing Cortical Oscillatory Responses in Major Depressive Disorder Before and After Convulsive Therapy: A TMS-EEG Study

Aron T. Hill, Itay Hadas, Reza Zomorrodi, Daphne Voineskos, Paul B. Fitzgerald, Daniel M. Blumberger, Zafiris J. Daskalakis

Summary: This study utilized TMS-EEG to investigate the differences in neural oscillatory dynamics between subjects with major depressive disorder (MDD) and healthy controls (HC), revealing increased oscillatory power in the DLPFC area in MDD subjects before treatment, and decreased power after convulsive therapy. These findings suggest that convulsive therapy may modulate neural oscillatory activity in MDD.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Editorial Material Psychiatry

Advancing the use of non-invasive brain stimulation through systematic data review

Paul B. Fitzgerald

BRAZILIAN JOURNAL OF PSYCHIATRY (2021)

Article Psychiatry

The place of non-invasive brain stimulation in the RANZCP clinical practice guidelines for mood disorders

Paul B. Fitzgerald, Shane Gill, Salam Hussain, Shanthi Sarma, Suneel Chamoli, Alan Weiss, David Garside, Subramanian Purushothaman, Matthew Fasnacht, Brett Simpson, Tibi Csizmadia, Carol Dean, Colleen Loo

Summary: Clinical practice guidelines play a crucial role in shaping clinical practice, but the recently published guideline for managing patients with mood disorders, specifically in regards to repetitive transcranial magnetic stimulation for depression treatment, has significant flaws and contradictions with scientific literature.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2021)

Editorial Material Psychiatry

The 'difficult-to-treat depression' and the 'response paradigm' models: Implications and relevance to patient management

R. H. McAllister-Williams, S. T. Aaronson, C. R. Conway, K. Demyttenaere, P. B. Fitzgerald, C. K. Loo, P. B. Mitchell, A. J. Rush, H. A. Sackeim, A. H. Young

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2021)

Article Neurosciences

Repetitive Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Meta-analysis of Randomized, Sham-Controlled Trials

M. Prabhavi N. Perera, Sudaraka Mallawaarachchi, Aleksandra Miljevic, Neil W. Bailey, Sally E. Herring, Paul B. Fitzgerald

Summary: This meta-analysis of 26 studies suggests that rTMS treatment has a modest effect on reducing OCD symptoms, with targeting the bilateral dorsolateral prefrontal cortex being the most effective approach. High-frequency and low-frequency rTMS show comparable effects, and the effects of active rTMS remain significantly superior to sham treatment 4 weeks post-treatment.

BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING (2021)

Article Psychiatry

The evidence is in: Repetitive transcranial magnetic stimulation is an effective, safe and well-tolerated treatment for patients with major depressive disorder

Paul B. Fitzgerald, Mark S. George, Saxby Pridmore

Summary: Despite over 25 years of research establishing the antidepressant efficacy of repetitive transcranial magnetic stimulation, there is still uncertainty surrounding the depth and breadth of this evidence base. However, numerous studies have shown that repetitive transcranial magnetic stimulation is effective in treating depression, with meta-analyses and umbrella reviews indicating that it may be more effective than other alternatives for patients with treatment-resistant depression. Additionally, real-world studies have confirmed meaningful response and remission rates in over 5000 patients, suggesting that repetitive transcranial magnetic stimulation should be a routine part of clinical care.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2022)

Review Clinical Neurology

High-frequency rTMS over the dorsolateral prefrontal cortex on chronic and provoked pain: A systematic review and meta-analysis

Xianwei Che, Robin F. H. Cash, Xi Luo, Hong Luo, Xiaodong Lu, Feng Xu, Yu-Feng Zang, Paul B. Fitzgerald, Bernadette M. Fitzgibbon

Summary: The study found that high-frequency rTMS stimulation of the DLPFC has significant short-term analgesic effects on neuropathic pain. There is also an overall pain reduction in the midterm and long term, as well as significant analgesic effect on provoked pain following HF-rTMS over the DLPFC.

BRAIN STIMULATION (2021)

Article Psychiatry

Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again

Paul B. Fitzgerald, Shane Gill, Michael Breakspear, Jayashri Kulkarni, Leo Chen, Saxby Pridmore, Subramanian Purushothaman, Cherrie Galletly, Patrick Clarke, Felicity Ng, Salam Hussain, Suneel Chamoli, Tibi Csizmadia, Patrick Tolan, Luca Cocchi, Samir Ibrahim Oam, Kavitha Shankar, Shanthi Sarma, Michael Lau, Colleen Loo, Tarun Yadav, Kate E. Hoy

Summary: This article discusses the controversy surrounding repetitive transcranial magnetic stimulation treatment of depression as addressed in the Royal Australian and New Zealand Journal of Psychiatry, while also highlighting the strong evidence supporting the safety, effectiveness, and cost-effectiveness of this treatment method.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2022)

Review Neurosciences

Electroencephalographic Connectivity: A Fundamental Guide and Checklist for Optimal Study Design and Evaluation

Aleksandra Miljevic, Neil W. Bailey, Fidel Vila-Rodriguez, Sally E. Herring, Paul B. Fitzgerald

Summary: Brain connectivity can be estimated through analysis of EEG data, but there is substantial heterogeneity in the implementation of connectivity methods. Standardization of processing and reporting can improve comparability and synthesizability of EEG connectivity studies. This article discusses factors influencing connectivity estimates and provides recommendations and a checklist for quality assessment.

BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING (2022)

Letter Clinical Neurology

A pilot study of fMRI targeted rTMS for obsessive compulsive disorder

Paul B. Fitzgerald, Rebecca Anne Segrave, Alex Fornito, Ben J. Harrison, Kate Hoy

BRAIN STIMULATION (2022)

Letter Psychiatry

Letter to the Editor regarding 'Five facts about rTMS?'

Paul B. Fitzgerald, Saxby Pridmore

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2023)

Article Psychiatry

Prescribing electroconvulsive therapy for depression: Not as simple as it used to be

Shane Gill, Salam Hussain, Subramanian Purushothaman, Shanthi Sarma, Alan Weiss, Suneel Chamoli, Matthew Fasnacht, Ashu Gandhi, Paul B. Fitzgerald, Brett Simpson, Colleen K. Loo

Summary: In the last century, the prescribing of electroconvulsive therapy involved considering unilateral versus bilateral treatment options. However, recent research has shown that various parameters of the therapy can significantly impact its effectiveness and cognitive side effects. The dose relative to seizure threshold and stimulus pulse width have been found to be particularly important factors in determining efficacy and side effects. This viewpoint aims to raise awareness among psychiatrists about the importance of considering these parameters when prescribing electroconvulsive therapy.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2023)

Review Clinical Neurology

Alterations in EEG functional connectivity in individuals with depression: A systematic review

Aleksandra Miljevic, Neil W. Bailey, Oscar W. Murphy, M. Prabhavi N. Perera, Paul B. Fitzgerald

Summary: The brain works as an organised, network-like structure of functionally interconnected regions, and disruptions to interconnectivity in certain networks have been linked to symptoms of depression and impairments in cognition. This systematic review aimed to synthesize evidence on EEG functional connectivity (FC) in depression. Fifty-two studies were identified, and while consistent findings were found in resting-state studies, no clear conclusions could be drawn about the direction of differences in FC due to inconsistencies in study design and methodology. More robust research is needed to understand the true differences in EEG FC in depression, as characterizing how FC differs in depression is essential for understanding its etiology.

JOURNAL OF AFFECTIVE DISORDERS (2023)

Article Health Care Sciences & Services

Repeated Transcranial Magnetic Stimulation for Improving Cognition in Patients With Alzheimer Disease: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Zahra Moussavi, Grant Rutherford, Brian Lithgow, Colleen Millikin, Mandana Modirrousta, Behzad Mansouri, Xikui Wang, Craig Omelan, Lesley Fellows, Paul Fitzgerald, Lisa Koski

Summary: This study aims to recruit up to 200 eligible participants to estimate the difference in treatment effects between active treatment and sham treatment, as well as between two doses of rTMS applications. The study design is a double-blind, randomized, placebo-controlled clinical trial investigating short- and long-term benefits of active rTMS treatment in patients with Alzheimer dementia. Preliminary results show promising outcomes and no serious adverse events as of November 2020.

JMIR RESEARCH PROTOCOLS (2021)

暂无数据